0000899243-17-024533.txt : 20171020 0000899243-17-024533.hdr.sgml : 20171020 20171020070109 ACCESSION NUMBER: 0000899243-17-024533 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171019 FILED AS OF DATE: 20171020 DATE AS OF CHANGE: 20171020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dasu Badri N CENTRAL INDEX KEY: 0001310803 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 171145931 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-19 0 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001310803 Dasu Badri N C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Engineering Officer Common Stock 2017-10-19 4 M 0 37500 1.20 A 74390 D Stock Option (Right to Buy) 1.20 2017-10-19 4 M 0 37500 0.00 D 2017-10-25 Common Stock 37500 0 D Balance includes non-reportable acquisition of 14,360 shares of Common Stock through the Company's Employee Stock Purchase Plan. Fully vested. /s/Martha Adler, Attorney-In-Fact 2017-10-19